Akèy › Kat vèt › Unicon Sciences, Inc.
Unicon Sciences, Inc.: sponso kat vèt (PERM)
Unicon Sciences, Inc. te depoze 8 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 6. Mwayèn salè yo ofri $60,000; mwayèn tan soti nan depozisyon jiska sètifikasyon: 442 jou.
Aplikasyon PERM8
Sètifye6
Salè medyan ofri$60,000
Mwayèn jou pou sètifikasyon442
Deja ap travay pou anplwayè a88%
Anplwaye (jan yo depoze)37
Nan biznis depi2015
Adrès anplwayèSouth Plainfield, NJ
Salè H-1B nan Unicon Sciences, Inc. →
Tit travay
| Tit travay | Aplikasyon PERM | Salè medyan |
|---|---|---|
| Clinical Study Associate | 5 | $60,000 |
| Clinical Research Associate | 3 | $108,306 |
Kote travay
Okipasyon
Dènye desizyon
| Tit travay | Salè baz | Kote | Soumèt | Deside | Estati | Jou |
|---|---|---|---|---|---|---|
| Clinical Research Associate | $108,306 | South Plainfield, NJ | Dec 4, 2024 | Apr 13, 2026 | Sètifye | 495 |
| Clinical Research Associate | $108,306 | South Plainfield, NJ | Dec 6, 2024 | Apr 10, 2026 | Sètifye | 490 |
| Clinical Research Associate | $108,306 | South Plainfield, NJ | Dec 9, 2024 | Jan 28, 2026 | Retire | — |
| Clinical Study Associate | $60,000 | South Plainfield, NJ | Jul 7, 2023 | Sep 15, 2024 | Sètifye | 436 |
| Clinical Study Associate | $60,000 | South Plainfield, NJ | Jul 21, 2023 | Sep 4, 2024 | Sètifye | 411 |
| Clinical Study Associate | $60,000 | South Plainfield, NJ | Jun 16, 2023 | Aug 29, 2024 | Sètifye | 440 |
| Clinical Study Associate | $60,000 | South Plainfield, NJ | Jun 8, 2023 | Aug 26, 2024 | Sètifye | 445 |
| Clinical Study Associate | $60,000 | South Plainfield, NJ | Aug 10, 2023 | Dec 12, 2023 | Retire | — |
Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).